Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations

被引:63
作者
Chang, JG
Lee, LS
Chen, CM
Shih, MC
Wu, MC
Tsai, FJ
Liang, DC
机构
[1] China Med Coll Hosp, Dept Lab Med, Taichung, Taiwan
[2] China Med Coll Hosp, Dept Pediat, Taichung, Taiwan
[3] Taipei Municipal Jen Ai Hosp, Dept Lab Med, Taipei, Taiwan
[4] Mackay Mem Hosp, Dept Pediat, Haematol Sect, Taipei, Taiwan
来源
PHARMACOGENETICS | 2002年 / 12卷 / 03期
关键词
thiopurine methyltransferase; drug metabolizing enzyme; polymorphism; South-east Asia; PCR-RFLP analysis;
D O I
10.1097/00008571-200204000-00003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Thiopurine S-methyltransferase (TPMT) catalyses the S-methylation of thiopurine drugs. In Caucasians, four variant TPMT alleles have been detected in over 80% of individuals with low or intermediate TPMT activity. The wild-type allele is designated as TPMT 1 and the mutant alleles are designated TPMT*2 through TPMT*8. The frequency of these alleles in different ethnic groups has not been well defined. In this study, one hundred individuals, from each of the Indonesian, Thai and Philippine populations, together with 249 Taiwanese, were analysed by polymerase chain reaction-restriction fragment length polymorphism and direct sequencing methods. The results showed that the allelic frequencies of TPMT*3C were 0.6% for Taiwanese and 1% for Filipino, Thai and Indonesian populations, respectively. One Filipino with a Caucasian parent was found to be heterozygous for the TPMT*2 allele. This study provides the first analysis of the allele frequency distribution of all known TPMT mutations in South-east Asian populations. Pharmacogenetics 12:191-195 (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 35 条
  • [1] Alves S, 1999, PHARMACOGENETICS, V9, P257
  • [2] Thiopurine methyltransferase alleles in British and Ghanaian populations
    Ameyaw, MM
    Collie-Duguid, ESR
    Powrie, RH
    Ofori-Adjei, D
    McLeod, HL
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (02) : 367 - 370
  • [3] CHANG JG, 1992, BLOOD, V80, P2092
  • [4] Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers
    Chang, JG
    Su, TH
    Wei, HJ
    Wang, JC
    Cheng, YJ
    Chang, CP
    Jeng, CJ
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) : 445 - 450
  • [5] The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations
    Collie-Duguid, ESR
    Pritchard, SC
    Powrie, RH
    Sludden, J
    Collier, DA
    Li, T
    McLeod, HL
    [J]. PHARMACOGENETICS, 1999, 9 (01): : 37 - 42
  • [6] de la Moureyre CSV, 1998, HUM MUTAT, V12, P177, DOI 10.1002/(SICI)1098-1004(1998)12:3<177::AID-HUMU5>3.0.CO
  • [7] 2-E
  • [8] THE PURINE PATH TO CHEMOTHERAPY
    ELION, GB
    [J]. SCIENCE, 1989, 244 (4900) : 41 - 47
  • [9] ALTERED MERCAPTOPURINE METABOLISM, TOXIC EFFECTS, AND DOSAGE REQUIREMENT IN A THIOPURINE METHYLTRANSFERASE-DEFICIENT CHILD WITH ACUTE LYMPHOCYTIC-LEUKEMIA
    EVANS, WE
    HORNER, M
    CHU, YQ
    KALWINSKY, D
    ROBERTS, WM
    [J]. JOURNAL OF PEDIATRICS, 1991, 119 (06) : 985 - 989
  • [10] Hiratsuka M, 2000, BIOL PHARM BULL, V23, P1090